Archford Capital Strategies’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $230K | Sell |
6,825
-1,522
| -18% | -$51.3K | 0.03% | 293 |
|
|
2025
Q1 | $265K | Sell |
8,347
-19
| -0.2% | -$604 | 0.04% | 260 |
|
|
2024
Q4 | $325K | Sell |
8,366
-517
| -6% | -$20.1K | 0.05% | 222 |
|
|
2024
Q3 | $395K | Sell |
8,883
-335
| -4% | -$14.9K | 0.06% | 194 |
|
|
2024
Q2 | $385K | Buy |
9,218
+3,426
| +59% | +$143K | 0.06% | 195 |
|
|
2024
Q1 | $264K | Buy |
5,792
+23
| +0.4% | +$1.05K | 0.04% | 233 |
|
|
2023
Q4 | $267K | Buy |
5,769
+777
| +16% | +$35.9K | 0.05% | 218 |
|
|
2023
Q3 | $203K | Sell |
4,992
-32
| -0.6% | -$1.3K | 0.04% | 260 |
|
|
2023
Q2 | $246K | Sell |
5,024
-184
| -4% | -$9.01K | 0.05% | 254 |
|
|
2023
Q1 | $251K | Buy |
5,208
+241
| +5% | +$11.6K | 0.05% | 249 |
|
|
2022
Q4 | $251K | Sell |
4,967
-774
| -13% | -$39.2K | 0.06% | 246 |
|
|
2022
Q3 | $288K | Sell |
5,741
-169
| -3% | -$8.48K | 0.07% | 231 |
|
|
2022
Q2 | $289K | Buy |
5,910
+129
| +2% | +$6.31K | 0.07% | 232 |
|
|
2022
Q1 | $357K | Buy |
5,781
+403
| +7% | +$24.9K | 0.08% | 215 |
|
|
2021
Q4 | $427K | Buy |
+5,378
| New | +$427K | 0.1% | 207 |
|